# __Oxford Properties and Novaxia Forge Strategic Partnership to Boost Life Sciences in France__, from ([11309.0](https://kghosh.substack.com/p/11309.0).)

__[External link](https://www.novaxia.fr/actualites/un-milliard-deuros-pour-creer-des-lieux-dinnovation-dedies-aux-life-sciences-en-france-oxford-properties-et-novaxia-concluent-un-partenariat-strategique/)__



## Keywords

* Oxford Properties
* Novaxia
* investissement immobilier
* Life Sciences
* biotechnologie
* partenariat
* France

## Themes

* partenariat strat√©gique
* investissement
* Life Sciences
* immobilier
* biotechnologie
* France

## Other

* Category: science
* Type: news

## Summary

Oxford Properties Group and Novaxia have announced a strategic partnership aimed at co-investing over one billion euros in Life Sciences real estate in France by 2024, starting in the Paris region. This collaboration seeks to address the growing need for high-tech infrastructure in the Life Sciences sector, which has seen a significant increase in venture capital investments post-COVID-19. The partnership will focus on developing laboratories, research centers, and production facilities to support biotechnology and medical technology companies. The initiative is part of a broader effort by the French government to strengthen the country's health sovereignty and foster innovation in Life Sciences.

## Signals

| name                                          | description                                                                            | change                                                                                        | 10-year                                                                                 | driving-force                                                                      |   relevancy |
|:----------------------------------------------|:---------------------------------------------------------------------------------------|:----------------------------------------------------------------------------------------------|:----------------------------------------------------------------------------------------|:-----------------------------------------------------------------------------------|------------:|
| Growth in Life Sciences Investments           | Life Sciences sector investments are increasing significantly in France post-COVID-19. | Shift from limited investments to significant growth in Life Sciences funding.                | In 10 years, France may become a leading hub for Life Sciences innovations in Europe.   | Government prioritization of health infrastructure and innovation post-pandemic.   |           5 |
| Partnerships in Real Estate and Life Sciences | Strategic partnerships are forming between real estate and Life Sciences sectors.      | Transition from isolated investments to integrated partnerships in Life Sciences real estate. | In 10 years, partnerships may redefine urban development focused on innovation.         | Growing demand for specialized infrastructure to support Life Sciences industries. |           4 |
| Urban Recycling for Innovation                | Obsolete buildings are being repurposed for Life Sciences innovations.                 | Shift from traditional real estate use to innovative Life Sciences facilities.                | In 10 years, urban areas may be transformed into innovation hubs for Life Sciences.     | Need for adaptable spaces to support the evolving Life Sciences landscape.         |           4 |
| Government Investment in Health               | French government is increasing investments in health and Life Sciences sectors.       | Change from minimal government support to substantial funding initiatives.                    | In 10 years, government investment may solidify France's position in global health R&D. | Response to pandemic pressures and the need for health sovereignty.                |           5 |
| Rise of Biotechnology Start-ups               | Biotechnology start-ups are experiencing accelerated growth and funding.               | Shift from slow growth to rapid expansion of biotech firms.                                   | In 10 years, a thriving ecosystem of biotech start-ups may emerge in France.            | Increased capital venture investments and supportive ecosystems for innovation.    |           5 |

## Behaviors

| name                                           | description                                                                                                                                |   relevancy |
|:-----------------------------------------------|:-------------------------------------------------------------------------------------------------------------------------------------------|------------:|
| Strategic Co-Investment in Life Sciences       | Oxford Properties and Novaxia have formed a strategic partnership to invest over a billion euros in Life Sciences real estate in France.   |           5 |
| Urban Recycling for Innovation                 | Novaxia is adapting obsolete buildings into facilities for Life Sciences innovation, promoting urban recycling and sustainability.         |           4 |
| Accelerated Growth in Biotechnology Investment | Venture capital investments in French biotech startups have doubled, indicating a growing interest and funding availability in the sector. |           5 |
| Creation of Specialized Infrastructure         | The need for high-tech real estate tailored to Life Sciences is emerging as essential for supporting biotech development.                  |           5 |
| Government Support for Health Innovation       | The French government is increasing investments in health sectors post-pandemic to strengthen local Life Sciences ecosystems.              |           4 |
| Global Ecosystem Development                   | Oxford aims to create a global ecosystem for Life Sciences companies, facilitating research and product development.                       |           4 |
| Adaptable Real Estate Solutions                | There is a growing demand for innovative real estate solutions that can serve multiple functions in research and development.              |           4 |
| Focus on Local Market Expertise                | The partnership leverages local market knowledge to effectively meet the needs of Life Sciences companies in France.                       |           4 |
| Rise of Incubators and Accelerators            | Investment is shifting towards the establishment of incubators and accelerators to support biotechnology firms in their growth phases.     |           5 |

## Technologies

| name                                           | description                                                                                                                                 |   relevancy |
|:-----------------------------------------------|:--------------------------------------------------------------------------------------------------------------------------------------------|------------:|
| Life Sciences Real Estate Investment           | Investment in high-tech real estate to support the growth of the life sciences sector in France, including labs and research centers.       |           5 |
| Biotechnology and Medical Technology Start-ups | Increase in venture capital investments in biotechnology start-ups, doubling from 2020 to 2021, indicating a thriving innovation ecosystem. |           5 |
| Urban Recycling for Life Sciences              | Repurposing obsolete buildings into innovation hubs for life sciences, fostering sustainable urban development.                             |           4 |
| Research and Development Laboratories          | Development of specialized laboratories (L1 to L3) that meet the technical needs of life sciences research.                                 |           5 |
| Incubators and Accelerators for Life Sciences  | Creation of incubator and accelerator spaces to support biotechnology companies and enhance innovation.                                     |           5 |
| Government Investment in Health Sector         | Increased government funding for health and life sciences to bolster research and innovation capabilities in France.                        |           4 |
| Global Life Sciences Ecosystem                 | Creation of a global ecosystem for life sciences companies to incubate, research, and develop therapies.                                    |           5 |

## Issues

| name                                              | description                                                                                                                                  |   relevancy |
|:--------------------------------------------------|:---------------------------------------------------------------------------------------------------------------------------------------------|------------:|
| Growth of Life Sciences Sector in France          | The Life Sciences sector in France is experiencing rapid growth due to increased investment and government support post-COVID-19.            |           5 |
| Shortage of Life Sciences Infrastructure          | There is a significant lack of laboratories and specialized facilities needed for Life Sciences research and development in France.          |           5 |
| Urban Recycling for Scientific Innovation         | Novaxia's initiative to repurpose obsolete buildings into Life Sciences facilities highlights a trend in urban recycling for innovation.     |           4 |
| Increased Venture Capital for Biotechnology       | Venture capital investments in French biotechnology startups have doubled, indicating growing confidence and opportunities in the sector.    |           4 |
| Government Support for Health Sectors             | French government initiatives like 'France Relance' and 'France 2030' aim to boost investments in health and Life Sciences infrastructure.   |           5 |
| Emergence of New Business Models in Life Sciences | The rapid pace of technological advancements is prompting new business models in the Life Sciences sector, favoring startups and innovation. |           4 |
| International Competition in Life Sciences        | France's need to maintain its sovereignty in health and compete with established markets like the U.S. is becoming increasingly important.   |           5 |
| Synergistic Partnerships in Life Sciences         | Collaboration between real estate and Life Sciences companies reflects a growing trend in creating supportive ecosystems for innovation.     |           4 |